Written Question·Department of Health and Social Care·UIN 12370

Vorasidenib

Tabled: 4 November 2024

Answered: 11 November 2024

Question

Andrew Rosindell

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of vorasdenib for treatment of low-grade gliomas.

Answer

Karin Smyth

It is critical that medicines used in the United Kingdom are safe and effective and as such, medicines cannot be marketed in the UK without a marketing authorisation. These are granted by the Medicines and Healthcare products Regulatory Agency (MHRA) whic...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 12370) →